Introducing Twelve Converter! Real-time currency rates at your fingertips. Available on Android, iOS soon!

ALNY

304.91 USD
0.35
0.11%
Last update Jun 2, 3:52 PM EDT
Main market
Day range
299.53
307.35
Previous close
304.56000
Open
305.7
Access this stock data via API
Subscribe
Alnylam Pharmaceuticals Inc.
304.91
0.35
0.11%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 2.2B 1.8B 1.0B 844.3M
Cost of revenue 323.4M 310.4M 168.8M 140.1M
Gross profit 1.9B 1.5B 868.6M 704.1M
Operating expense
Research & development 1.1B 1.0B 883.0M 792.2M
Selling general and admin 975.5M 795.6M 770.7M 620.6M
Other operating expenses
Operating income -176.9M -282.2M -785.1M -708.7M
Non operating interest income
Income 122.0M 95.6M 24.8M 1.6M
Expense 141.9M 121.2M 156.0M 143.0M
Other income expense -180.6M -125.7M -210.8M -2.1M
Pretax income -377.4M -433.5M -1.1B -852.1M
Tax provision -99.2M 6.7M 4.2M 680K
Net income -278.2M -440.2M -1.1B -852.8M
Basic EPS -3.5 -9.3 -7.2
Diluted EPS -3.5 -9.3 -7.2
Basic average shares 124.9M 121.7M 118.5M
Diluted average shares 124.9M 121.7M 118.5M
EBITDA -5.1M -107.3M -680.9M -636.7M
Net income from continuing op. -278.2M -440.2M -1.1B -852.8M
Minority interests
Preferred stock dividends
Main market

Exchange is currently active.
Closing in 6 minutes

15:53
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).